Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab ...Middle East

HONG KONG, Jan. 26, 2023 /PRNewswire/ -- Akeso, Inc. (9926. HK) ("Akeso" or the "Company"), a commercial-stage biopharmaceutical company focused on developing and commercializing first-in-class and best-in-class innovative medicines globally, announced the Hart-Scott-Rodino (HSR) Act...

Hence then, the article about akeso received first tranche of us 300 million upfront payment from summit summit is accelerating clinical development of ivonescimab was published today ( Thursday 26/01/2023 - 03:44 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Akeso Received First Tranche of US$300 Million Upfront Payment from Summit! Summit Is Accelerating Clinical Development of Ivonescimab )

Also on site :

• Watch last video of ‘All That’ star Kianna Underwood who died in hit-and-run at 33
• A Recent Tragedy Has Left My Kids Devastated. But I’m Secretly Pleased.
• Refugee-student housing project in EU state rocked by rape scandal